Applications of 2-Bromo-2-Nitropropane in Industrial Manufacturing

As an established manufacturer of 2-Bromo-2-Nitropropane, we supply this key intermediate to critical sectors with well-defined processing and formulation requirements. Below, we outline proven application scenarios, each reflecting precise market demands, process specifications, and compliance systems sourced directly from our global industrial client base.

1. Synthesis of Nitroalkane-Based Agrochemical Intermediates

Major agrochemical producers incorporate 2-Bromo-2-Nitropropane in nitration and alkylation steps when manufacturing select herbicide and pesticide actives. The compound’s reactivity supports the efficient construction of carbamate, nitrile, and pyrazole ring structures required for innovative crop protection molecules. Each batch undergoes strict traceability protocols to ensure raw material control from initial formulation to downstream synthesis blocks.

Industry compliance standards

• Regulation (EC) No 1107/2009 (EU Plant Protection Products)
• US EPA 40 CFR Part 174 (Pesticide Registration)
• ISO 9001:2015 for chemical manufacturing traceability
• China GB/T 31270.2—2014 Agrochemical Quality Requirements

Typical usage ratio

• 5–15% weight in intermediates batch, optimized to stoichiometry of the specific agrochemical synthesis route; adjustment based on active structure and yield targets

Downstream process integration

• Dosed directly into phase-transfer catalyzed alkylation or nitro condensation reactors, typically as initial charge following solvent loading in closed processing systems

Final product types

• Active ingredient intermediates for triazole and phenoxy herbicides
• Finished technical grade pesticides
• Seed treatment actives

2. Manufacture of Pharmaceutical Synthesis Intermediates

Active pharmaceutical ingredient (API) manufacturers use this material as a protected nitroalkyl source for constructing beta-nitroketone motifs, especially in cardiovascular, CNS, and antiviral drug processes. Its performance as a leaving group assures high selectivity in controlled nucleophilic substitutions. Pharmaceutical production facilities integrate it under strong GMP oversight to ensure raw material identity and consistency throughout multi-stage synthesis campaigns.

Industry compliance standards

• ICH Q7 (GMP for APIs)
• 21 CFR Part 211 (FDA cGMP)
• European Pharmacopoeia (Ph. Eur. monograph 2037)
• Chinese Pharmacopoeia (ChP)

Typical usage ratio

• 2–8% molar equivalent in targeted stepwise synthesis, precisely calculated based on desired nitroalkane moiety and stage yield

Downstream process integration

• Introduced at the protected group addition phase or as a brominating agent in continuous flow or batch reactors, followed by subsequent deprotection or reduction steps

Final product types

• Key intermediates for beta-blockers
• Intermediates for antiretroviral APIs
• Precursors for anti-inflammatory agents

3. Fine Chemical Synthesis of Organic Building Blocks

Producers of high-value fine chemicals deploy 2-Bromo-2-Nitropropane for phase-specific nitration, alkylation, and substitution reactions, supporting the commercial-scale synthesis of specialty nitroalkanes used in colorant, fragrance, and specialty monomer markets. These manufacturers maintain fully documented batch records to ensure product quality and regulatory traceability at every point of the supply chain.

Industry compliance standards

• ISO 9001:2015 (Quality Management)
• REACH Regulation (EC 1907/2006) – Registration of Substances
• US TSCA Inventory Listing (Industrial Chemicals)
• Japan CSCL (Chemical Substances Control Law)

Typical usage ratio

• 3–12% weight relative to the targeted fine chemical output, rate determined by reactivity, purity targets, and in-process yield monitoring

Downstream process integration

• Added via metered dosing into batch or semi-batch reactors at the alkylation or nucleophilic substitution stage, followed by extraction and purification

Final product types

• Functionalized nitroalkanes
• Specialty intermediates for dyes and pigments
• Precursors for monomers in advanced materials

4. Synthesis of Analytical Reagents and Diagnostic Kits

Companies specializing in analytical grade and diagnostic reagent manufacturing use this intermediate to prepare bromonitroalkane standards and derivatization agents, which enable precise quantification in chromatographic and spectrometric assays. Its defined purity and reactivity profile allows controlled production of calibration compounds and labeling agents in compliance with analytical laboratory standards worldwide.

Industry compliance standards

• ISO 17034 (Reference Material Producers)
• ISO/IEC 17025 (Analytical Laboratory Competence)
• USP General Chapter <1040> (Analytical Reagents)
• OECD GLP Principles

Typical usage ratio

• 0.5–3% weight/weight in labeling or derivatization formulations, adjusted for required sensitivity or calibration concentration

Downstream process integration

• Blended directly with target matrices or used in situ for bromonitroalkane reagent synthesis during final reagent formulation stage under controlled, cleanroom protocols

Final product types

• Chromatography calibration standards
• Diagnostic kit reagents for biological analysis
• Analytical derivatization agents